BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2468036)

  • 1. [Removal of middle molecule peptides from the blood during hemodialysis].
    Bakaev VV; Khomenko VF
    Lab Delo; 1989; (1):64. PubMed ID: 2468036
    [No Abstract]   [Full Text] [Related]  

  • 2. [Uremic middle-molecule toxins and their removal in hemofiltration].
    Kazakov IV; Timokhov VS
    Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
    [No Abstract]   [Full Text] [Related]  

  • 3. What remains of the "middle molecule" hypothesis today?
    Brunner H; Mann H
    Contrib Nephrol; 1985; 44():14-39. PubMed ID: 3886282
    [No Abstract]   [Full Text] [Related]  

  • 4. Removal of waste metabolites in uremia by microencapsulated reactants.
    Sparks RE; Salemme RM; Meier PM; Litt MH; Lindan O
    Trans Am Soc Artif Intern Organs; 1969; 15():353-9. PubMed ID: 5791409
    [No Abstract]   [Full Text] [Related]  

  • 5. The ultimate salt war? Uraemic toxins are all that count in dialysis patients.
    Vanholder R
    Nephrol Dial Transplant; 2012 Jan; 27(1):62-6. PubMed ID: 22287703
    [No Abstract]   [Full Text] [Related]  

  • 6. Do we need new indicators of dialysis adequacy based on middle-molecule removal?
    Vanholder R; Eloot S; Van Biesen W
    Nat Clin Pract Nephrol; 2008 Apr; 4(4):174-5. PubMed ID: 18268526
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum middle molecules in uremia.
    Buzio C; Manari A; Calderini C; Montagna G; Migone L
    Artif Organs; 1981; 4 Suppl():143-50. PubMed ID: 7295081
    [No Abstract]   [Full Text] [Related]  

  • 8. [Middle molecules and the problem of endogenous intoxication in critical states of various etiologies].
    Vladyka AS; Levitskiĭ ER; Poddubnaia LP; Gabriélian NI
    Anesteziol Reanimatol; 1987; (2):37-42. PubMed ID: 3300433
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid improvement of uremic neuropathy on short high-efficiency hemodialysis with special reference to middle molecules.
    Manohar NL; Gorfien PC; Namba T; Louis BM; Lipner HI
    ASAIO Trans; 1987; 33(3):274-9. PubMed ID: 3675953
    [No Abstract]   [Full Text] [Related]  

  • 10. Rationale for combined hemoperfusion/hemodialysis in uremia.
    Winchester JF; Ronco C; Brady JA; Brendolan A; Davankov V; Tsyurupa M; Pavlova L; Pavlov M; Clemmer J; Polaschegg HD; Muller TE; La Greca G; Levin NW
    Contrib Nephrol; 2001; (133):174-9. PubMed ID: 11477750
    [No Abstract]   [Full Text] [Related]  

  • 11. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.
    Smeby LC; Jörstad S; Wideröe TE; Svartaas TM
    Artif Organs; 1981; 4 Suppl():104-9. PubMed ID: 7295075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity?
    Vanholder R; Van Laecke S; Glorieux G
    J Nephrol; 2008; 21(2):146-60. PubMed ID: 18446708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of high-molecular-weight toxins.
    Hörl WH
    Contrib Nephrol; 1992; 96():138-44. PubMed ID: 1740048
    [No Abstract]   [Full Text] [Related]  

  • 14. Low flux dialysis? Still a role.
    Hoenich NA
    Contrib Nephrol; 2002; (137):189-92. PubMed ID: 12101953
    [No Abstract]   [Full Text] [Related]  

  • 15. Middle molecule definition in terms of membrane permeability.
    Klein E
    Artif Organs; 1981; 4 Suppl():46-50. PubMed ID: 7295095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemosorption as a treatment method for uremic complications].
    Pilotovich VS; Ostapenko VA; Shilaĭ LM; Kirkovskiĭ VV; Nikolaĭchik VV
    Klin Med (Mosk); 1982 Apr; 60(4):77-80. PubMed ID: 7098397
    [No Abstract]   [Full Text] [Related]  

  • 17. Uremic middle molecules: separation and quantitation.
    Chapman GV; Farrell PC
    Artif Organs; 1981; 4 Suppl():160-5. PubMed ID: 7295084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous measurement of DTPA-clearance in extracorporeal detoxification circuits.
    Falkenhagen D; Ahrenholz P; Roy T; Esther G; Kiencke H; Klinkmann H
    Artif Organs; 1981; 4 Suppl():166-8. PubMed ID: 7295085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R; Emond C; Claret G; Branger B; Mion H; Mion C
    Artif Organs; 1981; 4 Suppl():177-83. PubMed ID: 7295089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adequacy of dialysis.
    Lindsay RM; Henderson LW
    Kidney Int Suppl; 1988 Mar; 24():S92-9. PubMed ID: 3283413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.